Japan's Takeda mulls bid for British firm Shire to boost drug portfolio

Japan's Takeda mulls bid for British firm Shire to boost drug portfolio

REUTERS/Arnd Wiegmann

John Lauerman, James Paton

28 March, 2018

GlaxoSmithKline Plc.Novartis AGShire PlcTakeda Pharmaceutical Co.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from World

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.